Veronica Zeng, Ph.D.Principal Scientist, Discovery Biology & Pharmacol at Xencor, Inc.Speaker
Agenda Sessions
Tumor-Targeted CD28 Bispecific Antibodies Costimulate T Cells in the Tumor Microenvironment
, 16:25View Session